Uveoretinal Adverse Effects Presented during Systemic Anticancer Chemotherapy: a 10-Year Single Center Experience.

Ah Ran Cho Young Hee Yoon June-Gone Kim Yoon Jeon Kim Joo Yong Lee

Published in: Journal of Korean medical science (2018)

Uveoretinal complications were mostly mild to moderate and exhibited a favorable response to conservative therapy. A considerable number of patients exhibited significant irreversible loss of vision after cessation of the causative chemotherapeutic agent. Ophthalmological monitoring is required during chemotherapy.

Keyphrases

end stage renal disease
newly diagnosed
locally advanced
peritoneal dialysis
prognostic factors
risk factors
radiation therapy
mesenchymal stem cells
rectal cancer
smoking cessation